Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cf7f3f36d20185ce15a2d1f04d5fdc1 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1652 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
filingDate |
2006-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e4c0be0a29b9b1a178707d5852a3156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab45bc9ead37f197b83ceecb6d203d95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a55f807b8ed11e3768da87b5d718abd0 |
publicationDate |
2008-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-1912626-A1 |
titleOfInvention |
Dosage forms with improved bioavailability |
abstract |
A solid dispersion product comprising an effective amount of one or more active ingredients and an effective amount of one or more hydroxypropyl methylcellulose(s), which satisfies the Formula 0.35 > ΔHtr (1) (wherein AHtr represents the endotherm (J/g) accompanying a transition at about 240° C). The solid dispersion product is used for the manufacture of a dosage form having improved bioavailability of said one or more active ingredients by oral administration to a patient in need thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9757338-B2 |
priorityDate |
2005-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |